Investments
-
Ft. Washington’s Vitae Pharma Closes Stock Sale
Vitae Pharmaceuticals Inc., a Fort Washington biotechnology company, closed its public stock offering. It generated $35 million in proceeds, writes John George of the Philadelphia Business Journal. Vitae sold 5.83 million shares of common stock at $6 per share. According to George, that amount of the offering could grow by another $5.25 million. That is if underwriters…
Founding Partners
Advertisement
Affiliate Partners
Community Partners
